Spineart secured more than CHF20 million in convertible financing following completion of BAGUERA®C IDE studies enrollment for strategic initiatives in novel enabling technologies, patient follow-up, R&D and Training Center and new factory construction.
Amount Raised
CHF20 Million
Round Type
Convertible Note
Plan-les-OuatesBiotechnologyHealth CareMedicalMedical DeviceDescription
Spineart has successfully raised a CHF20 million convertible financing, with approximately CHF16 million of the funding contributed by existing shareholders and employees, and the remaining portion sourced from new investors, above the CHF20 million initial target. The proceeds will be used for investments in novel enabling technologies, patient follow-up, R&D and Training Center opening in Dallas, and completion of a new factory near Geneva by the end of 2024.
Quick answer
Spineart raised CHF20 Million in a Convertible Note round, dated March 18, 2024. Spineart is based in Plan-les-Ouates, Geneva, Switzerland.
- How much did Spineart raise?
- Spineart raised CHF20 Million in a Convertible Note round on March 18, 2024.
- What does Spineart do?
- Spineart is a privately held medical device company focused on simplifying the surgical act by designing, developing and promoting safe and efficient solutions to spine surgeons, operating room teams, and patients.
- Where is Spineart based and how big is it?
- Spineart is based in Plan-les-Ouates, Geneva, Switzerland.
- Who are the decision-makers at Spineart?
- Fundz holds 1 contact at Spineart. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Medical and Medical Device around the same time
Companies in the same sectors as Spineart that raised within 45 days of this round, from Fundz verified event records.
- neuroClues raised $5.4M (Pre-Series A) on April 30, 2024.
- AtaCor Medical raised $28M (Series C) on April 24, 2024.
- Nami Surgical raised $123K (Pre-Seed) on April 22, 2024.
- Flyte raised $5M (Seed) on April 22, 2024.
- Elucent Medical raised $43M (Series C) on April 10, 2024.
- Neurovalens raised $2.7M (Seed) on April 8, 2024.
Who to call at Spineart, and when
A new round usually means Spineart is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Spineart raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Spineart, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Spineart. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Spineart raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Spineart raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.